+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infertility Treatment Market by Product Type, Treatment Type, Diagnosis, End User - Global Forecast to 2030- Product Image
Infertility Treatment Market by Product Type, Treatment Type, Diagnosis, End User - Global Forecast to 2030- Product Image
Sale

Infertility Treatment Market by Product Type, Treatment Type, Diagnosis, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533339
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Infertility Treatment Market grew from USD 5.93 billion in 2024 to USD 6.58 billion in 2025. It is expected to continue growing at a CAGR of 11.32%, reaching USD 11.30 billion by 2030.

Understanding the Critical Imperative in Infertility Care

Infertility represents a profound clinical and emotional journey for individuals and couples worldwide, underscoring the urgency for innovative treatment solutions and data-driven market intelligence. As demographic trends shift and reproductive health priorities ascend on national agendas, the infertility treatment landscape demands closer examination to empower stakeholders in life sciences, bioengineering, pharmaceuticals, and clinical services. This executive summary distills the intricate dynamics of this complex ecosystem, outlining key trends, supply chain considerations, evolving treatment modalities, and competitive parameters that define the current state of the market.

By weaving together technological advancements, regulatory shifts, and socioeconomic factors, this analysis provides a coherent foundation for industry decision-makers. The insights presented herein are grounded in rigorous research methodologies designed to eliminate bias and foster actionable recommendations. Whether you are a medical device manufacturer, a diagnostic laboratory, a fertility clinic operator, or an investor evaluating growth opportunities, this introduction sets the stage for understanding the multifaceted challenges and opportunities that characterize the infertility treatment sector.

Driving the Future through Technological and Societal Transformation

The infertility treatment sector is undergoing seismic shifts driven by breakthroughs in reproductive biology, digital health, and patient engagement models. Artificial intelligence algorithms are now capable of analyzing embryo viability with greater precision, reducing time to pregnancy and improving clinical outcomes. In parallel, telemedicine platforms are democratizing access to fertility consultations, enabling patients in remote regions to connect with top specialists without the burden of travel. These technological innovations are compounded by a growing emphasis on personalized medicine, where genomic screening and biomarker panels guide tailored treatment plans.

Regulatory landscapes are also evolving, with several jurisdictions streamlining approval pathways for cryopreservation products and in vitro fertilization equipment to meet rising demand. Simultaneously, ethical considerations around gene editing and preimplantation genetic diagnosis are intensifying public discourse, prompting industry leaders to adopt transparent governance frameworks. Sociocultural shifts-such as delayed parenthood, increased acceptance of single-parent families, and legislative support for reproductive rights-are further reshaping patient profiles. Together, these transformative forces are redefining best practices and compelling stakeholders to recalibrate strategies for sustainable growth.

Unpacking Tariff-Driven Market Realignment in 2025

The implementation of United States tariffs in 2025 has introduced pronounced ripple effects across the global infertility treatment supply chain, particularly affecting imported equipment, media, and consumables. Elevated duties on cryosystems, imaging platforms, and micromanipulators have led manufacturers to reassess production footprints and sourcing strategies. Some original equipment providers have shifted component fabrication to domestic facilities, while others are exploring tariff mitigation through free trade agreements and bonded warehousing to maintain pricing competitiveness.

These adjustments have inevitably influenced treatment costs, putting pressure on clinics to optimize operational efficiency and on distributors to renegotiate supplier terms. Fertility drugs and diagnostic reagents, often imported from specialized suppliers, have also seen incremental price increases. In response, regional manufacturers are accelerating investments in local research and development to address unmet needs and capture a growing share of the market. Navigating this new tariff environment requires stakeholders to engage in proactive scenario planning, diversify supplier networks, and advocate for policy adjustments that align trade regulations with public health imperatives.

Dissecting Market Dynamics through Holistic Segment Analysis

The infertility treatment market encapsulates a diverse array of products, services, and end users, each contributing unique value propositions to clinical workflows. Product offerings span essential accessories, advanced equipment such as laser systems and sperm analyzer devices, and critical media and consumables like cryopreservation and culture media, underscoring the interconnected nature of laboratory operations and patient care. Within treatment modalities, artificial insemination techniques including intracervical, intratubal, and intrauterine procedures coexist alongside cutting-edge assisted reproductive technologies such as in vitro fertilization, intracytoplasmic sperm injection, and preimplantation genetic diagnosis. Fertility drugs ranging from clomiphene citrate to metformin play a central role in ovulation induction, while surgical interventions-from laparoscopy to varicocele repair-address anatomical factors.

Diagnostic approaches bifurcate into female and male infertility assessments, encompassing ovulation testing, hysterosalpingography, semen analysis, and testicular biopsy to pinpoint underlying causes. The end-user landscape brings together specialized fertility clinics, research institutes pioneering new protocols, hospitals integrating reproductive health into broader care pathways, and cryobanks safeguarding genetic materials. Insights derived from this segmentation framework enable stakeholders to tailor product development, align marketing strategies with treatment pathways, and prioritize investments in high-growth subsegments.

Regional Nuances Shaping Infertility Treatment Growth Trajectories

Regional dynamics shape the trajectory of the infertility treatment sector, with nuanced drivers evident across Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, established reimbursement frameworks and widespread insurance coverage catalyze adoption of advanced ART procedures, while robust academic-industry collaborations accelerate the translation of research into commercial applications. Patient advocacy networks in North and South America further bolster awareness and funding for infertility therapies, creating a supportive environment for new entrants and established players alike.

In Europe Middle East & Africa, regulatory harmonization within the European Union contrasts with heterogeneous policy landscapes in emerging markets, driving bespoke entry strategies for market participants. Cultural attitudes toward family planning and varying degrees of healthcare infrastructure maturity inform localized approaches to clinic expansion and technology deployment. Asia-Pacific commandeers rapid growth, fueled by rising disposable incomes, governmental initiatives to counter declining birth rates, and expanding private healthcare ecosystems. Nations across East and South Asia are scaling up IVF capacities and investing in domestic manufacturing of consumables to meet burgeoning demand, positioning the region as a pivotal growth engine.

Competitive Landscape Shaped by Innovation and Collaboration

The competitive arena is defined by a blend of legacy manufacturers, specialized biotechnology firms, and emerging digital health startups. Established entities with broad product portfolios leverage integrated supply chain networks to deliver turnkey solutions, while niche players differentiate through innovation in embryo culture systems and next-generation cryopreservation media. Strategic alliances and mergers have become commonplace as companies seek to augment capabilities in genomic diagnostics, AI-driven embryo assessment, and minimally invasive fertility surgeries.

Investment in intellectual property and targeted acquisitions underpin many companies’ growth strategies, fostering expanded footprints in key geographic markets. Meanwhile, collaborations between equipment manufacturers and fertility clinics facilitate real-world validation of new technologies, accelerating time to market and fostering user-centric design enhancements. Startups focusing on at-home diagnostic kits and telehealth platforms are also gaining traction, compelling incumbents to explore open innovation models to remain competitive. This dynamic interplay between scale advantages and specialized expertise defines the contours of competitive differentiation.

Strategic Imperatives for Sustained Market Leadership

Industry leaders should prioritize integration of artificial intelligence and machine learning capabilities into existing platforms to enhance clinical decision support and optimize resource allocation. Strengthening partnerships with research institutions can accelerate the validation of novel biomarkers and streamline regulatory approvals for next-generation products. To mitigate supply chain vulnerabilities exposed by recent tariffs, stakeholders must diversify manufacturing bases and cultivate relationships with regional suppliers of critical components and consumables.

Personalized treatment pathways represent another frontier; investing in genomic profiling and patient stratification tools will yield differentiated service offerings. Clinics and distributors should also expand telehealth services to address accessibility gaps, leveraging digital platforms to engage patients throughout the treatment journey. Finally, developing transparent pricing models and demonstrating cost-effectiveness through real-world evidence will be essential to securing reimbursement and fostering patient trust in emerging therapies.

Robust Triangulation of Data for Objective Market Insights

This analysis synthesizes quantitative and qualitative data drawn from a multi-tiered research framework. The process commenced with an exhaustive review of peer-reviewed journals, industry white papers, regulatory filings, and patent databases. Secondary research insights were complemented by primary interviews with key opinion leaders, including clinical embryologists, healthcare administrators, and supply chain executives. Data triangulation methodologies ensured consistency across sources, mitigating biases and enhancing the reliability of findings.

Market segmentation and competitive positioning analyses were validated through workshops with subject matter experts, and scenario planning exercises tested the resilience of strategic recommendations under varying assumptions. Rigorous quality controls, including data integrity checks and peer reviews, underpin the final deliverables. Ethical guidelines were observed throughout to maintain confidentiality and objectivity, ensuring that conclusions reflect a balanced interpretation of the evolving infertility treatment ecosystem.

Synthesizing Insights to Navigate an Evolving Infertility Landscape

The infertility treatment market stands at a pivotal juncture, driven by rapid technological progress, shifting regulatory landscapes, and evolving patient expectations. Emerging trends such as AI-enhanced embryo selection, telemedicine-enabled care models, and decentralized manufacturing of consumables promise to transform clinical outcomes and broaden global access to fertility services. Meanwhile, regional dynamics and tariff policies underscore the importance of flexible supply chain strategies and localized market approaches.

As competition intensifies, stakeholders who align innovation pipelines with real-world clinical needs, foster collaborative research partnerships, and uphold transparent governance will emerge as leaders. By leveraging the insights and recommendations outlined in this report, industry participants can navigate complexities, seize growth opportunities, and ultimately contribute to a future where effective, personalized infertility treatments are within reach for patients worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Accessories
    • Equipment
      • Cryosystems
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Ovum Aspiration Pumps
      • Sperm Analyzer Systems
      • Sperm Separation Devices
    • Media & Consumables
      • Cryopreservation Media
      • Culture Media
  • Treatment Type
    • Artificial Insemination
      • Intracervical Insemination
      • Intratubal Insemination
      • Intrauterine Insemination
    • Assisted Reproductive Technology (ART)
      • Embryo Cryopreservation
      • In Vitro Fertilization (IVF)
      • Intracytoplasmic Sperm Injection (ICSI)
      • Preimplantation Genetic Diagnosis (PGD)
    • Fertility Drugs
      • Clomiphene Citrate
      • Gonadotropins
      • Letrozole
      • Metformin
    • Fertility Surgeries
      • Hysteroscopy
      • Laparoscopy
      • Myomectomy
      • Varicocele Repair
      • Varicocelectomy
  • Diagnosis
    • Female Infertility
      • Hysterosalpingography (HSG)
      • Ovulation Testing
    • Male Infertility
      • Blood Tests
      • Semen Analysis
      • Testicular Biopsy
  • End User
    • Cryobanks
    • Fertility Clinics
    • Hospitals
    • Research Institutes
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • AbbVie Inc.
  • Bayer AG
  • City Fertility Centre
  • CooperSurgical, Inc.
  • Cryoport Systems, LLC.
  • Embryolab
  • EQUIPO IVI, S. L.
  • Ferring International Center S.A.
  • FUJIFILM Irvine Scientific, Inc.
  • Genea Group
  • IVI AMERICA, LLC
  • Merck KGaA
  • Monash IVF
  • New Hope Fertility Clinic
  • Nova IVF Fertility
  • NOW-fertility SA
  • Ovum Woman and Child specialty Hospital
  • ReproTech LLC
  • Seegene, Inc.
  • TMRW Life Sciences, Inc.
  • Vitrolife Sweden AB

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Infertility Treatment Market, by Product Type
8.1. Introduction
8.2. Accessories
8.3. Equipment
8.3.1. Cryosystems
8.3.2. Gas Analyzers
8.3.3. Imaging Systems
8.3.4. Incubators
8.3.5. Laser Systems
8.3.6. Micromanipulator Systems
8.3.7. Microscopes
8.3.8. Ovum Aspiration Pumps
8.3.9. Sperm Analyzer Systems
8.3.10. Sperm Separation Devices
8.4. Media & Consumables
8.4.1. Cryopreservation Media
8.4.2. Culture Media
9. Infertility Treatment Market, by Treatment Type
9.1. Introduction
9.2. Artificial Insemination
9.2.1. Intracervical Insemination
9.2.2. Intratubal Insemination
9.2.3. Intrauterine Insemination
9.3. Assisted Reproductive Technology (ART)
9.3.1. Embryo Cryopreservation
9.3.2. In Vitro Fertilization (IVF)
9.3.3. Intracytoplasmic Sperm Injection (ICSI)
9.3.4. Preimplantation Genetic Diagnosis (PGD)
9.4. Fertility Drugs
9.4.1. Clomiphene Citrate
9.4.2. Gonadotropins
9.4.3. Letrozole
9.4.4. Metformin
9.5. Fertility Surgeries
9.5.1. Hysteroscopy
9.5.2. Laparoscopy
9.5.3. Myomectomy
9.5.4. Varicocele Repair
9.5.5. Varicocelectomy
10. Infertility Treatment Market, by Diagnosis
10.1. Introduction
10.2. Female Infertility
10.2.1. Hysterosalpingography (HSG)
10.2.2. Ovulation Testing
10.3. Male Infertility
10.3.1. Blood Tests
10.3.2. Semen Analysis
10.3.3. Testicular Biopsy
11. Infertility Treatment Market, by End User
11.1. Introduction
11.2. Cryobanks
11.3. Fertility Clinics
11.4. Hospitals
11.5. Research Institutes
12. Americas Infertility Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Infertility Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Infertility Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. Bayer AG
15.3.3. City Fertility Centre
15.3.4. CooperSurgical, Inc.
15.3.5. Cryoport Systems, LLC.
15.3.6. Embryolab
15.3.7. EQUIPO IVI, S. L.
15.3.8. Ferring International Center S.A.
15.3.9. FUJIFILM Irvine Scientific, Inc.
15.3.10. Genea Group
15.3.11. IVI AMERICA, LLC
15.3.12. Merck KGaA
15.3.13. Monash IVF
15.3.14. New Hope Fertility Clinic
15.3.15. Nova IVF Fertility
15.3.16. NOW-fertility SA
15.3.17. Ovum Woman and Child specialty Hospital
15.3.18. ReproTech LLC
15.3.19. Seegene, Inc.
15.3.20. TMRW Life Sciences, Inc.
15.3.21. Vitrolife Sweden AB
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. INFERTILITY TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. INFERTILITY TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. INFERTILITY TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. INFERTILITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INFERTILITY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION (IVF), BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS (PGD), BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 36. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LETROZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY METFORMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY (HSG), BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SEMEN ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TESTICULAR BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 70. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. CANADA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 92. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 93. CANADA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 96. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 97. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 98. CANADA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 99. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 100. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 101. CANADA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 104. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 105. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 108. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 112. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 113. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 120. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 165. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 166. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 168. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 169. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 170. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 171. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 172. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 173. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 174. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 177. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 178. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 180. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 181. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 182. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 183. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 184. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 185. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 186. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 193. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. ITALY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. ITALY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 201. ITALY INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 202. ITALY INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. ITALY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 204. ITALY INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 205. ITALY INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 206. ITALY INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 207. ITALY INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 208. ITALY INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 209. ITALY INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 210. ITALY INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 213. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 214. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 215. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 216. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 217. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 218. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 219. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 220. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 221. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 222. SPAIN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 261. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 262. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 263. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 264. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 265. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 266. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 267. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 268. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 269. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 270. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. QATAR INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. QATAR INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 285. QATAR INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 286. QATAR INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 287. QATAR INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 288. QATAR INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 289. QATAR INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 290. QATAR INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 291. QATAR INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 292. QATAR INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 293. QATAR INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 294. QATAR INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 297. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 298. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 299. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 300. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 301. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 302. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 303. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 304. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 305. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 306. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 309. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 310. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 311. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 312. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
TABLE 313. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
TABLE 314. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 315. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 316. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 317. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. NIGERIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. NIGERIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (US

Companies Mentioned

The companies profiled in this Infertility Treatment market report include:
  • AbbVie Inc.
  • Bayer AG
  • City Fertility Centre
  • CooperSurgical, Inc.
  • Cryoport Systems, LLC.
  • Embryolab
  • EQUIPO IVI, S. L.
  • Ferring International Center S.A.
  • FUJIFILM Irvine Scientific, Inc.
  • Genea Group
  • IVI AMERICA, LLC
  • Merck KGaA
  • Monash IVF
  • New Hope Fertility Clinic
  • Nova IVF Fertility
  • NOW-fertility SA
  • Ovum Woman and Child specialty Hospital
  • ReproTech LLC
  • Seegene, Inc.
  • TMRW Life Sciences, Inc.
  • Vitrolife Sweden AB

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.3 Billion
Compound Annual Growth Rate11.3%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Infertility Treatment - Global Strategic Business Report - Product Image

Infertility Treatment - Global Strategic Business Report

  • Report
  • 505 Pages
  • Global
From
Infertility Treatment Market Report 2025 - Product Image

Infertility Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Assisted Reproductive Technology Market by Technology (in Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030 - Product Image

Assisted Reproductive Technology Market by Technology (in Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030

  • Report
  • 321 Pages
  • Global
From
Infertility Treatment Market: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Image

Infertility Treatment Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • 320 Pages
  • Global
From
Human Reproductive Technologies - Global Strategic Business Report - Product Image

Human Reproductive Technologies - Global Strategic Business Report

  • Report
  • 167 Pages
  • Global
From

About the Infertility Drug Market

The Infertility Drug market is a subset of Sexual and Reproductive Health Drugs, which are used to treat a variety of conditions related to fertility, pregnancy, and sexual health. These drugs are used to treat infertility, endometriosis, polycystic ovary syndrome, and other reproductive health issues. They can also be used to induce ovulation, increase sperm count, and improve egg quality. In addition, they can be used to treat hormonal imbalances, which can affect fertility. Infertility drugs are typically prescribed by a doctor and can be taken orally or injected. Commonly prescribed drugs include clomiphene citrate, gonadotropins, and human chorionic gonadotropin. These drugs can be used in combination with other treatments, such as in vitro fertilization (IVF). Companies in the Infertility Drug market include Merck, Bayer, Teva Pharmaceuticals, and Ferring Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.